Breaking News

BioClinica Expands OA Imaging Offerings

New positioning device to meet trial demands

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

BioClinica has expanded its range of imaging services for clinical trials in the area of osteoarthritis (OA). The new positioning device is capable of yielding highly reproducible plain film radiographs capable of showing joint space narrowing changes of less than 0.2 mm per year, according to the company. Colin G. Miller Ph.D., BioClinica’s senior vice president of Medical Affairs, said, “BioClinica has been actively involved in the OA Imaging field for both Disease Modifying Osteoarthri...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters